MULTIPLE SCLEROSIS, MS
Clinical trials for MULTIPLE SCLEROSIS, MS explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS, MS trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, MS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major 7-Year trial seeks best MS treatment for kids
Disease control OngoingThis study aims to find out if two newer MS medications (ofatumumab and siponimod) work as well as or better than an existing one (fingolimod) in controlling relapses for children and teens aged 10-17. It will follow about 120 young patients for up to 7 years to compare how often…
Matched conditions: MULTIPLE SCLEROSIS, MS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Researchers track daily life impact of MS treatment
Knowledge-focused OngoingThis study aims to understand how a multiple sclerosis (MS) treatment called ofatumumab affects patients' quality of life in real-world settings. It will follow 302 adults in France for up to 12 months after they start the treatment, as prescribed by their neurologist. The main g…
Matched conditions: MULTIPLE SCLEROSIS, MS
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Researchers scour nordic health records to gauge safety of MS drug for pregnant women
Knowledge-focused OngoingThis study aims to find out if enough pregnant women with Multiple Sclerosis (MS) in Finland and Sweden used the medication interferon-beta during their second and third trimesters. Researchers are analyzing existing health records to count these cases. The goal is to determine i…
Matched conditions: MULTIPLE SCLEROSIS, MS
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC